Rusi Remedies Profile
Key Indicators
- Authorised Capital ₹ 2.00 Cr
as on 06-01-2025
- Paid Up Capital ₹ 2.50 M
as on 06-01-2025
- Company Age 36 Year, 11 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 6.72 Cr
as on 06-01-2025
- Revenue -22.28%
(FY 2022)
- Profit -46.16%
(FY 2022)
- Ebitda -103.91%
(FY 2022)
- Net Worth 15.78%
(FY 2022)
- Total Assets 7.43%
(FY 2022)
About Rusi Remedies
The Company is engaged in the Chemicals And Materials Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 2.00 Cr and a paid-up capital of Rs 2.50 M.
The company currently has active open charges totaling ₹6.72 Cr.
Ravi Jaiswal and Shruti Jaiswal serve as directors at the Company.
- CIN/LLPIN
U24200MH1988PTC046238
- Company No.
046238
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
16 Feb 1988
- Date of AGM
27 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Company Details
- Location
Mumbai, Maharashtra, India
- Telephone
- Email Address
- Website
-
- Social Media
What products or services does Rusi Remedies Private Limited offer?
Rusi Remedies Private Limited offers a wide range of products and services, including Ayurvedic,Herbal Products & Medicine, Herbal Piles Medicine, Pain Relief Drugs & Pharmaceuticals, Pain Relief Spray.
Who are the key members and board of directors at Rusi Remedies?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Ravi Jaiswal  | Director | 01-Jul-2014 | Current |
| Shruti Jaiswal | Director | 07-Nov-2015 | Current |
Financial Performance of Rusi Remedies.
Rusi Remedies Private Limited, for the financial year ended 2022, experienced significant reduction in revenue, with a 22.28% decrease. The company also saw a substantial fall in profitability, with a 46.16% decrease in profit. The company's net worth Soared by an impressive increase of 15.78%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Rusi Remedies?
In 2020, Rusi Remedies had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Bank Of Baroda Creation Date: 17 Aug 2004 | ₹5.70 Cr | Open |
Bank Of India Creation Date: 17 Aug 2004 | ₹6.00 M | Open |
Central Bank Of India Creation Date: 05 Feb 2000 | ₹2.00 M | Open |
How Many Employees Work at Rusi Remedies?
Rusi Remedies has a workforce of 12 employees as of Apr 08, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Rusi Remedies, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Rusi Remedies's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
